Ankasa Pharmaceuticals Llp - Due diligence report

A 360° intelligence report on Ankasa Pharmaceuticals Llp: trust score, financial health, credit view, compliance, directors, growth and dist…

2015-11-29 Thane, Maharashtra Active
Share
Connect MCP
AP Ankasa Pharmaceuticals Llp
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Ankasa Pharmaceuticals Llp — 360° Intelligence Report

Generated from MCA filings & public records
83/100
Trust Score
Low Risk

Ankasa Pharmaceuticals Llp is assessed as Low Risk with a Trust Score of 83/100. Ankasa Pharmaceuticals Llp is an active limited liability partnership incorporated in 2015, operating in the Business Services sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a low compliance risk and an unassessed financial risk profile.

Report generated on 12 Oct 2026 from the latest processed filings. Ankasa Pharmaceuticals Llp snapshot & full profile →

Financial Health › No Data
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
83/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
75/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreNo Data
N/A
No processed financial statements available yet.
Credit Risk ScoreNo Data
N/A
Financial statements needed for a credit view.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreNo Data
N/A
Needs at least two filed years to measure growth.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

No processed financials
Financial statements are not yet processed for this company. Trend analysis will appear once filings are available.
04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: N/A No Data
  • Financial statements needed for a credit view.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 75/100 Low Risk
  • Company status is Active as per MCA.
  • Last balance sheet is for Mar 2017 - filings overdue.
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
SARIKA KASHINATH MANDARE 01234567 Director 01/04/2018 6 yrs Approved
HEMANGI SANTOSH SALUNKE 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth N/A · Distress 80
Growth signals & trust indicators
Operating for 10+ years.
Financials unavailable - score leans on compliance and governance signals.
Distress signals & risk flags
Statutory filings appear overdue.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence79/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • No financials on record - ask for audited statements.
Banker assessment70/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • No filed financials - rely on banking statements and GST data.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view63/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Request management accounts - public filings insufficient.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 5 events
31 Mar 2018
Last AGM held
Annual general meeting
31 Mar 2017
Latest balance sheet
Filed with ROC
29 Nov 2015
Incorporated
Registered with Roc Mumbai
Director appointed
SARIKA KASHINATH MANDARE (Designated Partner)
Director appointed
HEMANGI SANTOSH SALUNKE (Designated Partner)
10

Key Observations

Auto-generated from the data above
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
J&L SAMARTH KRUPA LLP ACD-2666 Thane, Maharashtra
Varun Management Services Private Limited U74120MH2014PTC252567 Thane, Maharashtra
Flying Tiger Entertainment Private Limited U74999MH2015PTC265303 Thane, Maharashtra
Prajala Enterprises Private Limited U55101MH2021PTC367364 Thane, Maharashtra
JEEVSATTVA ORGANIC LLP AAU-3360 Thane, Maharashtra
Viradha Engineering And Projects India Private Limited U28999MH2022PTC393665 Thane, Maharashtra
Prasinos Planitis Renewable Energies Private Limited U74999MH2019PTC322551 Thane, Maharashtra
Tilibandha Sales Agencies Private Limited U74999MH2018PTC313096 Thane, Maharashtra
Natify E-Comm Private Limited U52390MH2022PTC390427 Thane, Maharashtra
Rks Securityservices (Opc) Private Limited U80100MH2024OPC424220 Thane, Maharashtra
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Ankasa Pharmaceuticals Llp before audits and certifications: compliance score 75/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Ankasa Pharmaceuticals Llp: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score pending financials, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score n/a, margin trends, ownership structure and peer set for Ankasa Pharmaceuticals Llp - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 83/100, distress signals and MSME payment-delay disclosures - know whether Ankasa Pharmaceuticals Llp pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Ankasa Pharmaceuticals Llp - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Ankasa Pharmaceuticals Llp an active company?

Ankasa Pharmaceuticals Llp has MCA status “Active” with a compliance score of 75/100 (Low Risk).

Is Ankasa Pharmaceuticals Llp financially healthy?

Processed financial statements are not yet available for Ankasa Pharmaceuticals Llp, so its financial health is unassessed.

Should I do business with Ankasa Pharmaceuticals Llp?

Its overall Trust Score is 83/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Ankasa Pharmaceuticals Llp?

See the directors and ownership sections above for board and shareholding detail. 2 active director(s) are on record.

Does Ankasa Pharmaceuticals Llp have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Ankasa Pharmaceuticals Llp up to date with its ROC filings?

Last balance sheet is for Mar 2017 - filings overdue. Overall compliance score: 75/100 (Low Risk).

Is it risky to lend to Ankasa Pharmaceuticals Llp?

Filed financial statements are needed for a credit view - ask the company for audited statements and bank statements.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.